Rockefeller Capital Management’s Regencell Bioscience RGC Stock Holding History
Bought
Maintained
Sold
Other funds holding RGC
Rockefeller Capital Management's RGC Position: Q3 2026 in Review
Rockefeller Capital Management held its Regencell Bioscience (RGC) position steady in Q3 2026 at 505 shares worth $3.14K. The position accounts for ﹤0.01% of the portfolio, ranked #4492.
Rockefeller Capital Management first reported a position in RGC in Q4 2025 and has held it in 4 quarters since. 25 funds tracked by Wall St. Rank hold RGC as of Q3 2026.
- Rockefeller Capital Management held 505 shares of Regencell Bioscience worth $3.14K as of Q3 2026.
- Rockefeller Capital Management left its Regencell Bioscience share count unchanged in Q3 2026.
- Regencell Bioscience made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4492 holding.
- Rockefeller Capital Management first reported a position in Regencell Bioscience in Q4 2025 and has held it in 4 quarters since.
- 25 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.